SCN5A splicing variants and the possibility of predicting heart failure-associated arrhythmia

Research output: Contribution to journalEditorialpeer-review

6 Scopus citations
Original languageEnglish (US)
Pages (from-to)117-119
Number of pages3
JournalExpert review of cardiovascular therapy
Issue number2
StatePublished - Feb 2013

Bibliographical note

Funding Information:
The authors were supported by R01 HL106592, R01 HL104025, P01 HL058000 and a VA MERIT grant. SC Dudley is an inventor of intellectual property entiltled, ‘SCN5A Splice Variants for Use in Methods Relating to Sudden Cardiac Death and Need for Implanted Cardiac Defibrillators,’ and is a founder of ROS Diagnostics, a company developing a blood test for sudden death. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.


  • RNA splicing
  • blood test
  • heart
  • heart failure
  • sodium channel
  • sudden death

Cite this